|
Market Cap (2-Jul) $738,750,080 (468th) |
Close (30-Jun) $0.55 |
Volume (30-Jun) 827,047 |
Shortsold (19-Jun) 41,649,705 (3.38%) (73rd) |
|
52w High $1.17 |
52w Low $0.335 |
P/E 6.75 |
EPS -0.43 |
OPT released this announcement to the ASX on 15 March 2021, 8:32. The announcement is marked as price sensitive, and is 4 page(s) in length and 159.51kb in size.
You can view all announcements from OPT and see how they appear on a price chart on the announcements page.
At the date of this announcement, OPT was 2.930% short sold according to ASIC data. It was ranked the 62nd most shorted stock on the ASX. It remains ranked 73rd as of the latest reported data (19 June 2025).
| Other Recent Announcements from OPT | |
|---|---|
| Change in substantial holding | 23 June 2023, 16:51 |
| Final Director's Interest Notice MS | 9 June 2023, 8:16 |
| Initial Director's Interest Notice AT | 9 June 2023, 8:15 |
| Opthea Treats First Patient in Phase 3 Trials of OPT-302 | 15 March 2021, 8:32 |
| Opthea to Present at Oppenheimer Healthcare Conference | 10 March 2021, 8:32 |
| Change of Director's Interest Notice - MS | 5 March 2021, 17:47 |
| Change of Director's Interest Notice - MB | 5 March 2021, 17:44 |
You must be logged in to post a reply.
Opthea 